Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Cancer|April 13, 2001
Comparison of prognostic models in patients with advanced Hodgkin disease. Promising results from integration of the best three systemsP G Gobbi, P L Zinzani, C Broglia, et al.Brazilian Journal of Physical Therapy|March 20, 2015
Are 30 minutes of rest between two incremental shuttle walking tests enough for cardiovascular variables and perceived exertion to return to baseline values?Laís R G Ribeiro, Rafael B Mesquita, Laís S Vidotto, et al.British Journal of Haematology|July 1, 1989
T-cell receptor genes expression in B-cell leukaemiasF Narni, M T Mariano, A Colò, et al.Physiotherapy|November 28, 2018
Effects of exercise training in water and on land in patients with COPD: a randomised clinical trialJ M Felcar, V S Probst, D R de Carvalho, et al.Haematologica|November 1, 1996
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL)P G Gobbi, C Pieresca, L Cavanna, et al.Haematologica|February 22, 2000
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registryC Stelitano, L Baldini, C Pieresca, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2006
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL)P G Gobbi, C Broglia, F Valentino, et al.Bone Marrow Transplantation|December 6, 2005
The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL)F Morabito, C Stelitano, S Luminari, et al.Blood|May 16, 1998
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's diseaseP G Gobbi, C Pieresca, M L Ghirardelli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Image-aided estimate of tumor burden in Hodgkin's disease: evidence of its primary prognostic importanceP G Gobbi, M L Ghirardelli, M Solcia, et al.Pageof 3